Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/18/24 17:46 | 9/16/24 | FDMT | Health | BioPrd | Biological Products, (No Diag | Bizily Scott | CA | O | GC | 14 | S.d | -1,130 | 28.35 | 0 | -40 | 7 | D | |||||||||||||||
7/12/24 17:46 | 7/10/24 | FDMT | Health | BioPrd | Biological Products, (No Diag | Kirn David | CA | DO | CEO | 5 | S.dm | -5,149 | 22.80 | 0 | -226 | 1,157 | D | |||||||||||||||
2/7/24 20:32 | 2/5/24 | FDMT | Health | BioPrd | Biological Products, (No Diag | Kim Robert Young | CA | O | Chief Me | 1 | S.d | -738 | 30.05 | 0 | -25 | 1 | D | |||||||||||||||
1/5/24 17:44 | 1/4/24 | FDMT | Health | BioPrd | Biological Products, (No Diag | Viking Global Investors LP | CT | T | 1 | S | -10,546 | 19.53 | 0 | -540 | 4,248 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |